Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.
about
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyPaucity of initial cerebrospinal fluid inflammation in cryptococcal meningitis is associated with subsequent immune reconstitution inflammatory syndromeTargeting the intragraft microenvironment and the development of chronic allograft rejectionPotential dual immunomodulatory role of VEGF in ulcerative colitis and colorectal carcinomaSecretion of immunoregulatory cytokines by mesenchymal stem cells.CD47 signaling regulates the immunosuppressive activity of VEGF in T cells.Vascular endothelial growth factor receptor inhibitor SU5416 suppresses lymphocyte generation and immune responses in mice by increasing plasma corticosterone.AAV5-mediated sFLT01 gene therapy arrests retinal lesions in Ccl2(-/-)/Cx3cr1(-/-) miceOxazolone-induced contact hypersensitivity reduces lymphatic drainage but enhances the induction of adaptive immunity.Defining CD4 T cell memory by the epigenetic landscape of CpG DNA methylationEffect of vascular endothelial growth factor and its receptor KDR on the transendothelial migration and local trafficking of human T cells in vitro and in vivo.Molecular imaging of vascular endothelial growth factor receptors in graft arteriosclerosis.VEGF directly suppresses activation of T cells from ascites secondary to ovarian cancer via VEGF receptor type 2Epigenetic and transcriptional signatures of stable versus plastic differentiation of proinflammatory γδ T cell subsets.Relationship of VEGF/VEGFR with immune and cancer cells: staggering or forward?Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein.PI3K functions in cancer progression, anticancer immunity and immune evasion by tumors.Key Features of the Intragraft Microenvironment that Determine Long-Term Survival Following TransplantationNeuropilin 1: function and therapeutic potential in cancer.Chronic allograft rejection: a fresh look.The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance.Immune effects of bevacizumab: killing two birds with one stoneImmune cells regulate VEGF signalling via release of VEGF and antagonistic soluble VEGF receptor-1.Intraocular DHODH-inhibitor PP-001 suppresses relapsing experimental uveitis and cytokine production of human lymphocytes, but not of RPE cells.Immunohistochemical analysis of CD45RO+ T cells and vascular endothelial growth factor expression in cyclosporin A-induced rat gingival tissue.Targeting VEGF/VEGFR to Modulate Antitumor Immunity.Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.VEGF directly suppresses activation of T cells from ovarian cancer patients and healthy individuals via VEGF receptor Type 2
P2860
Q21144623-274BD204-E8EF-4CC5-A3A3-95D5C611B023Q24630287-E531C1B2-C4E2-45F2-9177-C02BF229F9D5Q26852762-684E26D1-3CEA-4DF1-944F-3EE0A9D731D8Q33962407-4C187CB6-79CB-4596-9DE1-658551757795Q34259098-B1AA446A-CC4C-4AB1-AF39-D32594D70FB6Q34289358-D77E2814-EF3C-4C0B-AE37-4F56A22A9608Q34997498-51D56A46-F104-49B1-8116-D529133B442BQ35106359-19174139-8B24-4EE3-9663-39A4B593AA28Q35184089-89DEA2E9-BE6E-4CA9-A47B-F33D4E5984A4Q35190948-1AE646F1-9DF8-4E72-9252-BF64E489BF17Q35215426-C202BF42-60C4-46F6-8556-A7A5F8023283Q36106634-781C70C6-A018-4C9B-BDAC-EBEF15CC0634Q36419140-0BE68721-3C6F-4C74-805F-7AC62042842EQ36807846-BE79C94E-BC3C-4687-9D26-F1A840987DBAQ37094060-4E15FF3A-9AD6-42D5-9D70-53556800F111Q37104090-3B7CA97A-E5BA-4F39-A94E-5630E4CDC4CCQ37951937-927598C3-4F01-4405-AB5D-C27D49EC57D2Q38008362-17B1F37A-1DF6-4C72-8483-1DE10360C33CQ38165001-F15BAB04-98E1-42FD-8A7E-F381840C066CQ38309271-96AECA67-CDF6-4D93-A58B-470BEF919516Q39023597-6F5866CE-02B9-43A4-828D-5D04613CA614Q41401879-87007251-A157-4E91-88E9-EC19AF0289EDQ48128395-C8D764A5-81CB-4A4C-8F22-0C67E2A5292AQ50326759-B752C5A9-5E8B-437D-8ADE-23FB83465F90Q51003492-957DC19D-F0F1-4F23-B59A-992856426101Q55008337-44DC149F-27E0-4F21-BD3E-A2D8F1B5A22FQ55190117-A4045F87-2E36-4B24-9C28-B69B1DE02960Q57904509-49B2CD23-F9C7-4250-9FFE-2E1570CD8AEA
P2860
Cutting edge: Vascular endothelial growth factor-mediated signaling in human CD45RO+ CD4+ T cells promotes Akt and ERK activation and costimulates IFN-gamma production.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@ast
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@en
type
label
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@ast
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@en
prefLabel
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@ast
Cutting edge: Vascular endothe ...... imulates IFN-gamma production.
@en
P2093
P2860
P356
P1476
Cutting edge: Vascular endothe ...... timulates IFN-gamma production
@en
P2093
Andre Hoerning
Aninda Basu
Dipak Datta
Katiana Calzadilla
Maria P Stack
Monika Edelbauer
Soumitro Pal
P2860
P304
P356
10.4049/JIMMUNOL.0900397
P407
P577
2009-12-11T00:00:00Z